Literature DB >> 15820712

The role of stress-induced cortisol in the relationship between depression and decreased bone mineral density.

Patricia M Furlan1, Tom Ten Have, Mark Cary, Babette Zemel, Felix Wehrli, Ira R Katz, David R Gettes, Dwight L Evans.   

Abstract

BACKGROUND: This study was designed to test the hypothesis that cortisol mediates the relationship between bone density and depression in postmenopausal women.
METHODS: Nineteen women aged 52-79 who had been assessed for bone mineral density by dual-energy x-ray absorptiometer (DEXA) were evaluated for depression and anxiety. Diurnal and stress-induced measures of salivary cortisol were obtained during the following week and at a laboratory session involving a speech task.
RESULTS: Nine volunteers reported depression while 10 were never depressed. Ever depressed women had significantly lower total lumbar and right femur DEXA Z scores than never depressed (t(17) = 2.5, p = .019 and t(17) = 2.06, p = .05, respectively). Ever depressed women demonstrated a significant increase in salivary cortisol (area under the curve (AUC) = 27.83, SD = 37.64) compared to never depressed women (AUC = -13.34, SD = 19.55) (t(17) = -3.041, p = .007) during a psychological challenge. There were significant inverse relationships between salivary cortisol AUC values and bone density Z scores at every measured bone site. Mediation analyses suggest that 51 - 67% of the association between depression and bone density could be attributed to stress-induced changes in cortisol.
CONCLUSIONS: Cortisol hypersecretion in response to stress may, in part, explain the impact of depression on bone density in post-menopausal women.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820712     DOI: 10.1016/j.biopsych.2004.12.033

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  16 in total

1.  Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis.

Authors:  Sifat Maria; Rebekah M Samsonraj; Fahima Munmun; Jessica Glas; Maria Silvestros; Mary P Kotlarczyk; Ryan Rylands; Amel Dudakovic; Andre J van Wijnen; Larry T Enderby; Holly Lassila; Bala Dodda; Vicki L Davis; Judy Balk; Matt Burow; Bruce A Bunnell; Paula A Witt-Enderby
Journal:  J Pineal Res       Date:  2018-01-17       Impact factor: 13.007

2.  Impact of depression and its treatment on the bones of growing children.

Authors:  Elizabeth B Weller; Ronald A Weller; Angelica L Kloos; Stacie Hitchcock; Woo J Kim; Babette Zemel
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

3.  Effects of long-term combination treatment with valproate and atypical antipsychotics on bone mineral density and bone metabolism in premenopausal patients with bipolar disorder: a preliminary study.

Authors:  Jaewon Yang; Sook-Haeng Joe; Moon-Soo Lee; Young-Hoon Ko; In-Kwa Jung; Seung-Hyun Kim
Journal:  Psychiatry Investig       Date:  2011-08-05       Impact factor: 2.505

4.  Depressive symptoms, bone loss, and fractures in postmenopausal women.

Authors:  Leslie Spangler; Delia Scholes; Robert L Brunner; John Robbins; Susan D Reed; Katherine M Newton; Jennifer L Melville; Andrea Z Lacroix
Journal:  J Gen Intern Med       Date:  2008-02-20       Impact factor: 5.128

Review 5.  Depression and low bone mineral density: a meta-analysis of epidemiologic studies.

Authors:  Q Wu; J H Magnus; J Liu; A F Bencaz; J G Hentz
Journal:  Osteoporos Int       Date:  2009-04-03       Impact factor: 4.507

6.  Bone density characteristics and major depressive disorder in adolescents.

Authors:  Pouneh K Fazeli; Nara Mendes; Melissa Russell; David B Herzog; Anne Klibanski; Madhusmita Misra
Journal:  Psychosom Med       Date:  2013-01-29       Impact factor: 4.312

Review 7.  Depression as a risk factor for osteoporosis.

Authors:  Giovanni Cizza; Svetlana Primma; Gyorgy Csako
Journal:  Trends Endocrinol Metab       Date:  2009-09-09       Impact factor: 12.015

8.  Temporary amygdala inhibition reduces stress effects in female mice.

Authors:  Jila Rezaeian Dalooei; Hedayat Sahraei; Gholam Hossein Meftahi; Maryam Khosravi; Zahra Bahari; Boshra Hatef; Alireza Mohammadi; Fateme Nicaeili; Fateme Eftekhari; Fateme Ghamari; Mohamadmehdi Hadipour; Gholamreza Kaka
Journal:  J Adv Res       Date:  2016-07-01       Impact factor: 10.479

9.  Depressive symptoms and bone mineral density in menopause and postmenopausal women: A still increasing and neglected problem.

Authors:  Abdulbari Bener; Najah M Saleh; Dinesh Bhugra
Journal:  J Family Med Prim Care       Date:  2016 Jan-Mar

10.  Depressive symptoms and bone mineral density among police officers in a northeastern US City.

Authors:  Luenda E Charles; Desta Fekedulegn; Diane B Miller; Jean Wactawski-Wende; John M Violanti; Michael E Andrew; Cecil M Burchfiel
Journal:  Glob J Health Sci       Date:  2012-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.